Welcome to the Wild, Wild West: the CGM head-to-head study
In the past at Diabettech, we’ve talked about how the design of a CGM safety and accuracy study plays a big part in the results […]
In the past at Diabettech, we’ve talked about how the design of a CGM safety and accuracy study plays a big part in the results […]
How do you compare two different CGMs? It seems like a stupid question. It’s obvious. You look at the Mean Absolute Relative Difference (MARD) of […]
It was only a little over a week ago that Abbott released their Libre Sense, offering up CGM for athletes without a medical approval, with […]
As many of us do going in to the new year, I made a decision to be more active, eat more healthily, etc. The usual […]
As many people with T1D in the UK will know, there has been an ongoing dialogue between NHS England and the DVLA with respect to […]
World Diabetes Day 2018. The day that NHS England had enough. The announcement If you hadn’t seen it, NHS England issued a press release early […]
The big question that remains for many more technical users in relation to the FreeStyle Libre 2 is whether it is transmitting glucose data or […]
Anyone watching the Twitter feed for the Advanced Technologies and Treatments for Diabetes 2018 conference can’t fail to have noticed that, once again, the answer […]
Earlier today, the first NHS England CCG response to the Libre appeared on Twitter, from the East of England Priorities Advisory Committee. Looking to the […]
Two days ago, Abbott announced they had received FDA approval for the Freestyle Libre, some 3 years after European approval. That feels like a long […]
Copyright © 2024 | WordPress Theme by MH Themes